Thank God there’s a cease sign for this practice wreck
The Australian Broadcasting Company writes
The Australian Securities Trade has suspended shares in certainly one of Australia's largest medical hashish producers after an auditor stated there was “inadequate proof” of future funding.
The Cann Group was the primary firm to be issued with a hashish analysis license by the Australian authorities's Drug Management Workplace in 2017.
It has invested $49 million in a medical hashish greenhouse on the outskirts of Mildura and employs about 40 folks.
On Friday, the corporate was suspended from buying and selling after a report by auditor William Buck stated the corporate and its administrators had been “unable to offer sufficiently satisfactory proof” of ample funding for the corporate to function. within the subsequent 12 months.
“As of the date of this report, the group has not been in a position to affirm its means to safe an satisfactory mixture of present and longer-term exterior monetary commitments to offer ample funding to help the group as a going concern,” he wrote the auditor.
In its half-year monetary report filed with the ASX on Thursday, Cann Group reported an working lack of $14.34 million within the half-year to December 31 and famous money owed for a worth of about $64 million.
The Cann Group was “in ongoing discussions with numerous events concerning financing/refinancing choices,” the monetary report stated.
As of December 31, the Cann Group had money readily available of $1.64 million and entry to $800,000 in a working capital facility.
It additionally had unused belongings at its Mildura web site that could possibly be bought for an estimated $1.7 million, the report stated.
The ABC has contacted Cann Group for remark.
https://www.abc.internet.au/information/rural/2024-03-01/medicinal-cannabis-cann-group-suspended-asx-funding-concerns/103534124
